Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.286, 2000-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
N-BNP levels a better treatment guide in heart failure?
Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. :
Access to resources
Recommend
Who should receive early ACE inhibitor therapy after MI?
Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. :
n-3 PUFA post-MI: worth the cost?
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :
Rosiglitazone and MI risk - will we ever know the answer?
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :
Increased risk of MI with tricyclics, but not SSRIs?
Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. :